3 completed, 3 recruiting, 2 unknown, 1 not yet recruiting. 9 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 9 | Completed 3, Recruiting 3, Unknown 2, Not yet recruiting 1 |
Follow Schizo Affective Disorder: new trials by email Literature Review of Schizo Affective Disorder trials Research Report on Schizo Affective Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Trial of an IL-23 Inhibitor for Immune Activation in Clinical Trial of an IL-23 Inhibitor for Immune Activation in People With Schizophrenia Placebo, IL-23 - Schizophrenia, Schizo Affective Disorder | Phase 4 | Not yet recruiting | University of Maryland, Baltimore | 40 | 2026-09-01 | 2026-05-29 |
| Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder Group Therapy Program, semaglutide, Phentermine-Topiramate - Bipolar I Disorder, Bipolar II Disorder | Phase 4 | Recruiting | Mayo Clinic | 100 | 2026-01-19 | 2026-03-11 |
| Metabolic Effects of Adjunctive Lumateperone Treatment in Clozapine-Treated Patients With Schizophrenia Lumateperone, Placebo - Schizophrenia, Schizo Affective Disorder | Phase 4 | Recruiting | University of Massachusetts, Worcester | 50 | 2024-04-02 | 2026-05-22 |
| Tachyphylaxis, Tolerance, & Withdrawal Post Treatment With Igalmi for Agitation in Schizophrenia or Bipolar Disorder Sublingual film containing Igalmi - Bipolar Disorder, Schizophrenia | Phase 4 | Completed | BioXcel Therapeutics Inc | 29 | 2023-10-02 | 2026-08-11 |
| Evaluating Sublingual Dexmedetomidine For Moderate To Severe Agitation In Inpatients With Schizophrenia Or Bipolar Disorder Dexmedetomidine, Lorazepam 2 MG/ML - Schizophrenia Agitation, Schizo Affective Disorder | Phase 4 | Unknown | Temple University | 32 | 2023-07-01 | 2023-10-23 |
| Multi-modal Assessment of Gamma-aminobutyric Acid (GABA) Function in Psychosis Placebo and fMRI, Lorazepam and fMRI - Schizophrenia, Bipolar Disorder | Phase 4 | Completed | University of Michigan | 143 | 2020-01-16 | 2026-06-17 |
| Bazedoxifene -Treatment for Women With Schizophrenia Bazedoxifene Acetate, Placebo - Schizophrenia, Schizophreniform Disorders | Phase 4 | Recruiting | The Alfred | 160 | 2019-10-07 | 2026-06-03 |
| DIMES - DIgital MEdicine Study for Adults With Schizophrenia, Bipolar I Disorder, or Major Depression Currently Using Aripiprazole ABILIFY MYCITE - Schizophrenia, Major Depressive Disorder | Phase 4 | Unknown | Durham VA Medical Center | 46 | 2019-04-04 | 2020-06-18 |
| Memantine Effects on Sensorimotor Gating and Neurocognition in Schizophrenia Memantine, Placebos - Schizophrenia, Schizo Affective Disorder | Phase 4 | Completed | University of California, San Diego | 42 | 2018-04-01 | 2022-12-21 |
Psychotic Disorders (9) · Schizophrenia (8) · Bipolar Disorder (5) · Psychomotor Agitation (2) · Depressive Disorder, Major (1) · Obesity (1) · Weight Loss (1)
Mental Disorders (9) · Schizophrenia Spectrum and Other Psychotic Disorders (9) · Bipolar and Related Disorders (5) · Mood Disorders (5) · Pathological Conditions, Signs and Symptoms (3) · Signs and Symptoms (3) · Aberrant Motor Behavior in Dementia (2) · Behavior (2) · Behavioral Symptoms (2) · Dyskinesias (2) · Nervous System Diseases (2) · Neurobehavioral Manifestations (2) · Neurologic Manifestations (2) · Psychomotor Disorders (2) · Body Weight (1)
Dexmedetomidine (2) · Lorazepam (2) · Interleukin-23 (1) · Memantine (1) · Naltrexone-Bupropion combination (1) · Qsymia (1) · bazedoxifene (1) · lumateperone (1) · semaglutide (1)
BioXcel Therapeutics Inc (1) · Durham VA Medical Center (1) · Mayo Clinic (1) · Temple University (1) · The Alfred (1) · University of California, San Diego (1) · University of Maryland, Baltimore (1) · University of Massachusetts, Worcester (1) · University of Michigan (1)
United States (8) · Australia (1)
BioXcel MM, MD (1) · Deanna L Kelly, PharmD, BCPP (1) · Hayden Bosworth, PhD (1) · Mark A Frye, M.D. (1) · Stephan Taylor, MD (1) · Xiaoduo Fan, MD (1)
R01MH118634 (1)